Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Japan 14.14
Resistance to osimertinib, a third-generation tyrosine kinase inhibitor targeting EGF receptor used as first-line therapy for patients with non-small cell lung cancer (NSCLC) harboring mutant EGFR, is mediated by IGF-1R signaling activated by IGF-2 in NSCLC cell lines (41)
Draw 2.0 mL bacteriostatic water with a sterile syringe
It helps the immune system function efficiently by supporting antioxidant enzymes that reduce oxidative stress during immune responses
US$ 27.45
.png)
US$ 27.11
![Mechanism of action of GLP-1 [25]](https://www.researchgate.net/publication/256289222/figure/fig1/AS:614177232142337@1523442671231/Mechanism-of-action-of-GLP-1-25.png)
US$ 28.16
US$ 23.72
US$ 26.29
US$ 26.89
